:::

詳目顯示

回上一頁
題名:新診斷糖尿病人自我照護因子及生活型態與血糖控制的關聯:縱貫性觀察研究
作者:謝芳傑
作者(外文):SIA, HONKE
校院名稱:亞洲大學
系所名稱:健康產業管理學系健康管理組
指導教授:王俊毅
學位類別:博士
出版日期:2021
主題關鍵詞:糖尿病血糖控制預測因子自我監測血糖吸菸diabetes mellitusglycemic controlpredictorsself-monitoring of blood glucosesmoking
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:0
  • 共同引用共同引用:0
  • 點閱點閱:1
研究背景:在罹病早期,良好的血糖控制可降低併發症的風險,甚至可能逆轉β細胞的功能障礙。因此新診斷糖尿病人需要盡快實現更好的血糖控制。本文目的是探討新診斷第2型糖尿病人之自我照護因子及生活型態與血糖控制的關聯,進行了三項研究。研究一,是辨識新診斷第2型糖尿病人在第一年血糖控制失敗的預測因子。研究二、三則針對自我監測血糖(自我照護因子)及吸菸(生活型態)進行縱貫型研究,評估這些因素對血糖控制的關聯及程度。
研究方法:本研究為縱貫型觀察性研究。以回顧方式,進行次級資料分析。研究對象為在2002年1月至2017年12月之間在台灣中部某醫學中心接受衛教及完成糖尿病照護系統登錄之新診斷第2型糖尿病人。使用電子病歷系統中的數據進行篩查。主要結果是血糖控制,以糖化血色素值進行評估。變項包括人口學資料,家族病史,生活型態(吸菸,飲酒和身體活動),臨床因素(包括身體檢查、實驗室檢驗、藥物使用及共病),自我照護因子(包括藥物依從性、自我監測血糖、疾病相關的知識及自我管理的意願)等。
結果:研究一顯示,研究參與者中有33.6%第一年治療失敗。基線糖化血色素值每增加1%,治療失敗的風險就上升為1.17倍(95%信賴區間,1.15至1.20)。男性、規律運動、進行自我監測血糖、藥物依從性佳以及近年
(2010至2017年)發病收案者,在所有模式中均有較低的治療失敗風險。研究二,根據模型估計的縱向糖化血色素軌跡,調整其他干擾變項後顯示,自我監測血糖「早期使用者」比「未早期使用者」的糖化血色素降幅大,組間的糖化血色素降幅差異為0.55%。次群體分析中,無論是使用胰島素增泌劑或非胰島素增泌劑,自我監測血糖皆與改善血糖控制顯著關聯。此外,較高自我監測血糖頻率(≥7次/週)與更大的糖化血色素降幅顯著關聯。雖然自我監測血糖的監測頻率會隨時間逐漸耗損,但血糖控制改善效果仍可持續到一年。研究三顯示,新診斷第2型糖尿病男性病人,在一年的觀察期間,吸菸者的血糖控制比不吸菸者差。兩組間的糖化血色素降幅差異約為0.25到0.33%。在身體質量指數<25 kg/m2者更為明顯,組間的糖化血色素降幅差異0.68到0.74%,顯示可能身體質量指數較低的男性病人吸菸與血糖控制間的負向關聯更強。
結論:本研究顯示自我監測血糖,藥物依從性和規律運動等自我照護行為及生活型態對新診斷第2型的糖尿病人避免治療失敗關聯甚大。男性病人吸菸與血糖控制不良有顯著關聯。
Background: Early glycemic control may have long-term effects in reducing the risk of diabetes related complications and reverse β cell dysfunction. Therefore, it is urgent to achieve optimal glycemic control in patients with newly diagnosed type 2 diabetes mellitus (T2DM).
This thesis was proposed to explore the association between self-care factors and lifestyles on glycemic control among adult patients with newly diagnosed T2DM. Three studies were separately conducted. The aim of study 1 was to identify factors that predict treatment failure during the first year in adult with newly diagnosed T2DM. The other two studies aimed to examine the longitudinal association between glycemic control and two major factors: self-monitoring of blood glucose (SMBG) and smoking, in non-insulin-treated patients and men, respectively.
Methods: The studies used secondary data analyses with retrospective longitudinal design. Adult patients who received diabetes education and completed registration at a medical center in Taiwan between January 2002 and December 2017 were screened for eligibility based on data from the hospital’s electronic medical record system. Glycemic control, the primary outcome, was assessed by repeated measures of hemoglobin A1c (HbA1c) levels. Covariate data on demographics, family history, lifestyles (habits and physical activity), physical examinations, laboratory tests, medications, adherence, knowledge regarding glycemic control, and willingness toward diabetes self-management were collected.
Results: Study 1 showed that 33.6% of participants were classified as treatment failure (TF) during the first year. For every 1% increase in baseline HbA1c, the
risk of TF was 1.17 (95%CI, 1.15−1.20) times higher. Gender (men), medication adherence, SMBG, regular exercise, and enrollment during 2010−2017 predicted a lower risk of TF in both of primary and subgroup models. In study 2, longitudinal HbA1c trajectory after adjustment of other control variables showed that early SMBG users had a lower estimated HbA1c reduction than non-users, with the maximal difference being 0.55%. Performing SMBG at disease onset was positively associated with better glycemic control in newly diagnosed non-insulin treated T2DM patients, regardless of whether non-insulin secretagogues or insulin secretagogues were used. In addition, higher SMBG frequency (≥ 7 times/week) was associated with greater HbA1c reduction. Study 3 demonstrated that smoking was independently associated with unfavorable glycemic control among men with newly diagnosed T2DM. The estimated difference in HbA1c reduction between smokers and non-smokers was 0.25 – 0.33. For those with body mass index < 25 kg/m2, the difference in HbA1c reduction was much remarkable.
Conclusions: Overall, the findings show that self-care behaviors and lifestyles, such as medication adherence, SMBG, and regular exercise were major predictors of treatment failure during the first year. In addition, the studies add evidence on the longitudinal associations of glycemic control with SMBG and smoking among patients with newly diagnosed T2DM.
中文部分

中華民國糖尿病學會(2018)。2018糖尿病臨床照護指引。台北:糖尿病學會。
王璟璇、王瑞霞、林秋菊(1998):自我照顧行為、自我效能和社會支持對初期非胰島素依賴型糖尿病患者血糖控制之影響。高雄醫學科學雜誌,14(12):807-815。
國民健康署(2018)。全民身體活動指引。台北:衛生福利部國民健康署。
曹亞英、唐迅、孫可欣(2016):2型糖尿病患者血糖控制與內臟脂肪指數的關係。北京大學學報 (醫學版),49(3):446-450。
黃憶玫、張慈桂(2011):糖尿病照護成效與影響因素之探討:以台東某區域醫院糖尿病共同照護網為例。台灣公共衛生雜誌, 30(1):19 - 28。DOI: 10.6288/TJPH2011-30-01-03
趙滿紅、鄭雙雙、王兆品等(2016):寧波市某社區糖尿病患者血糖控制的影響因素分析 。中國預防醫學雜誌,17(3):187-192 . DOI:10.16506/j.1009-6639.2016 .03.008
衛生福利部。108年國人死因統計表。2021年4月28日,取自:https://www.mohw.gov.tw/cp-16-54482-1.html
衛生福利部國民健康署。國人吸菸行為調查。2020年6月8日,取自:https://www.hpa.gov.tw/Pages/Detail.aspx?nodeid=1718&pid=9913
蘇健、覃玉、沈沖、高艷、潘恩春、潘曉群、陶然、張永青、武鳴(2017):吸菸和戒菸行為與男性2型糖尿病人血糖控制關係的研究。中華流行病學雜誌,38(11):1454-1459。

英文部分

Agardh, E., Allebeck, P., Hallqvist, J., Moradi, T., & Sidorchuk, A. (2011). Type 2 diabetes incidence and socio-economic position: a systematic review and meta-analysis. International journal of epidemiology, 40(3), 804–818. https://doi.org/10.1093/ije/dyr029
Akter, S., Goto, A., & Mizoue, T. (2017). Smoking and the risk of type 2 diabetes in Japan: A systematic review and meta-analysis. Journal of epidemiology, 27(12), 553–561. https://doi.org/10.1016/j.je.2016.12.017
Akter, S., Okazaki, H., Kuwahara, K., Miyamoto, T., Murakami, T., Shimizu, C., Shimizu, M., Tomita, K., Nagahama, S., Eguchi, M., Kochi, T., Imai, T., Nishihara, A., Sasaki, N., Nakagawa, T., Yamamoto, S., Honda, T., Uehara, A., Yamamoto, M., Hori, A., … Japan Epidemiology Collaboration on Occupational Health Study Group (2015). Smoking, Smoking Cessation, and the Risk of Type 2 Diabetes among Japanese Adults: Japan Epidemiology Collaboration on Occupational Health Study. PloS one, 10(7), e0132166. https://doi.org/10.1371/journal.pone.0132166
Amati, F., Dubé, J. J., Coen, P. M., Stefanovic-Racic, M., Toledo, F. G., & Goodpaster, B. H. (2009). Physical inactivity and obesity underlie the insulin resistance of aging. Diabetes care, 32(8), 1547–1549. https://doi.org/10.2337/dc09-0267
American Diabetes Association (2019). 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2019. Diabetes care, 42(Suppl 1), S13–S28. https://doi.org/10.2337/dc19-S002
American Diabetes Association (2019). 5. Lifestyle Management: Standards of Medical Care in Diabetes-2019. Diabetes care, 42(Suppl 1), S46–S60. https://doi.org/10.2337/dc19-S005
American Diabetes Association (2019). 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2019. Diabetes care, 42(Suppl 1), S90–S102. https://doi.org/10.2337/dc19-S009
American Diabetes Association (2020). 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2020. Diabetes care, 43(Suppl 1), S98–S110. https://doi.org/10.2337/dc20-S009
American Diabetes Association (2021). 12. Older Adults: Standards of Medical Care in Diabetes-2021. Diabetes care, 44(Suppl 1), S168–S179. https://doi.org/10.2337/dc21-S012
American Diabetes Association (2021). 5. Facilitating Behavior Change and Well-being to Improve Health Outcomes: Standards of Medical Care in Diabetes-2021. Diabetes care, 44(Suppl 1), S53–S72. https://doi.org/10.2337/dc21-S005
American Diabetes Association (2021). 6. Glycemic Targets: Standards of Medical Care in Diabetes-2021. Diabetes care, 44(Suppl 1), S73–S84. https://doi.org/10.2337/dc21-S006
American Diabetes Association (2021). 7. Diabetes Technology: Standards of Medical Care in Diabetes-2021. Diabetes care, 44(Suppl 1), S85–S99. https://doi.org/10.2337/dc21-S007
Anan, F., Takahashi, N., Shinohara, T., Nakagawa, M., Masaki, T., Katsuragi, I., Tanaka, K., Kakuma, T., Yonemochi, H., Eshima, N., Saikawa, T., & Yoshimatsu, H. (2006). Smoking is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients. European journal of clinical investigation, 36(7), 459–465. https://doi.org/10.1111/j.1365-2362.2006.01650.x
Antonio, J. P., Sarmento, R. A., & de Almeida, J. C. (2019). Diet Quality and Glycemic Control in Patients with Type 2 Diabetes. Journal of the Academy of Nutrition and Dietetics, 119(4), 652–658. https://doi.org/10.1016/j.jand.2018.11.006
Artha, I., Bhargah, A., Dharmawan, N. K., Pande, U. W., Triyana, K. A., Mahariski, P. A., Yuwono, J., Bhargah, V., Prabawa, I., Manuaba, I., & Rina, I. K. (2019). High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus. Vascular health and risk management, 15, 149–157. https://doi.org/10.2147/VHRM.S209830
Attvall, S., Fowelin, J., Lager, I., Von Schenck, H., & Smith, U. (1993). Smoking induces insulin resistance--a potential link with the insulin resistance syndrome. Journal of internal medicine, 233(4), 327–332. https://doi.org/10.1111/j.1365-2796.1993.tb00680.x
Audrain-McGovern, J., & Benowitz, N. L. (2011). Cigarette smoking, nicotine, and body weight. Clinical pharmacology and therapeutics, 90(1), 164–168. https://doi.org/10.1038/clpt.2011.105
Avery, L., Flynn, D., van Wersch, A., Sniehotta, F. F., & Trenell, M. I. (2012). Changing physical activity behavior in type 2 diabetes: a systematic review and meta-analysis of behavioral interventions. Diabetes care, 35(12), 2681–2689. https://doi.org/10.2337/dc11-2452
Baggio, B., Budakovic, A., Dalla Vestra, M., Saller, A., Bruseghin, M., & Fioretto, P. (2002). Effects of cigarette smoking on glomerular structure and function in type 2 diabetic patients. Journal of the American Society of Nephrology : JASN, 13(11), 2730–2736. https://doi.org/10.1097/01.asn.0000032422.81130.68
Bannay, A., Chaignot, C., Blotière, P. O., Basson, M., Weill, A., Ricordeau, P., & Alla, F. (2016). The Best Use of the Charlson Comorbidity Index With Electronic Health Care Database to Predict Mortality. Medical care, 54(2), 188–194. https://doi.org/10.1097/MLR.0000000000000471
Barnett, A. H., Krentz, A. J., Strojek, K., Sieradzki, J., Azizi, F., Embong, M., Imamoglu, S., Perusicová, J., Uliciansky, V., & Winkler, G. (2008). The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study). Diabetes, obesity & metabolism, 10(12), 1239–1247. https://doi.org/10.1111/j.1463-1326.2008.00894.x
Baron, J. A., La Vecchia, C., & Levi, F. (1990). The antiestrogenic effect of cigarette smoking in women. American journal of obstetrics and gynecology, 162(2), 502–514. https://doi.org/10.1016/0002-9378(90)90420-c
Beck, R. W., Connor, C. G., Mullen, D. M., Wesley, D. M., & Bergenstal, R. M. (2017). The Fallacy of Average: How Using HbA1c Alone to Assess Glycemic Control Can Be Misleading. Diabetes care, 40(8), 994–999. https://doi.org/10.2337/dc17-0636
Benoit, S. R., Fleming, R., Philis-Tsimikas, A., & Ji, M. (2005). Predictors of glycemic control among patients with Type 2 diabetes: a longitudinal study. BMC public health, 5, 36. https://doi.org/10.1186/1471-2458-5-36
Bermudez, E. A., Rifai, N., Buring, J. E., Manson, J. E., & Ridker, P. M. (2002). Relation between markers of systemic vascular inflammation and smoking in women. The American journal of cardiology, 89(9), 1117–1119. https://doi.org/10.1016/s0002-9149(02)02284-1
Beutler E. (1975). The effect of carbon monoxide on red cell life span in sickle cell disease. Blood, 46(2), 253–259.
Bijlsma-Rutte, A., Rutters, F., Elders, P., Bot, S., & Nijpels, G. (2018). Socio-economic status and HbA1c in type 2 diabetes: A systematic review and meta-analysis. Diabetes/metabolism research and reviews, 34(6), e3008. https://doi.org/10.1002/dmrr.3008
Bloomgarden, Z., & Handelsman, Y. (2018). How does CKD affect HbA1c? Journal of diabetes, 10(4), 270. https://doi.org/10.1111/1753-0407.12624
Boren S. A. (2007). AADE7TM Self-care Behaviors: systematic reviews. The Diabetes educator, 33(6), 866–871. https://doi.org/10.1177/0145721707309662
Borgharkar, S. S., & Das, S. S. (2019). Real-world evidence of glycemic control among patients with type 2 diabetes mellitus in India: the TIGHT study. BMJ open diabetes research & care, 7(1), e000654. https://doi.org/10.1136/bmjdrc-2019-000654
Bornemisza, P., & Suciu, I. (1980). Effect of cigarette smoking on the blood glucose level in normals and diabetics. Medecine interne, 18(4), 353–356.
Bosi, E., Scavini, M., Ceriello, A., Cucinotta, D., Tiengo, A., Marino, R., Bonizzoni, E., Giorgino, F., & PRISMA Study Group (2013). Intensive structured self-monitoring of blood glucose and glycemic control in noninsulin-treated type 2 diabetes: the PRISMA randomized trial. Diabetes care, 36(10), 2887–2894. https://doi.org/10.2337/dc13-0092
Boulé, N. G., Haddad, E., Kenny, G. P., Wells, G. A., & Sigal, R. J. (2001). Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA, 286(10), 1218–1227. https://doi.org/10.1001/jama.286.10.1218
Boulé, N. G., Kenny, G. P., Haddad, E., Wells, G. A., & Sigal, R. J. (2003). Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in Type 2 diabetes mellitus. Diabetologia, 46(8), 1071–1081.
https://doi.org/10.1007/s00125-003-1160-2
Bower, J. K., Meadows, R. J., Foster, M. C., Foraker, R. E., & Shoben, A. B. (2017). The Association of Percent Body Fat and Lean Mass With HbA1c in US Adults. Journal of the Endocrine Society, 1(6), 600–608. https://doi.org/10.1210/js.2017-00046
Bowker, S. L., Mitchell, C. G., Majumdar, S. R., Toth, E. L., & Johnson, J. A. (2004). Lack of insurance coverage for testing supplies is associated with poorer glycemic control in patients with type 2 diabetes. Canadian Medical Association journal, 171(1), 39–43. https://doi.org/10.1503/cmaj.1031830
Braveman, P. A., Cubbin, C., Egerter, S., Williams, D. R., & Pamuk, E. (2010). Socioeconomic disparities in health in the United States: what the patterns tell us. American journal of public health, 100 Suppl 1(Suppl 1), S186–S196. https://doi.org/10.2105/AJPH.2009.166082
Bretzel, R. G., Eckhard, M., Landgraf, W., Owens, D. R., & Linn, T. (2009). Initiating insulin therapy in type 2 diabetic patients failing on oral hypoglycemic agents: basal or prandial insulin? The APOLLO trial and beyond. Diabetes care, 32 Suppl 2(Suppl 2), S260–S265. https://doi.org/10.2337/dc09-S319
Brunton, S. A., & Polonsky, W. H. (2017). Hot Topics in Primary Care: Medication Adherence in Type 2 Diabetes Mellitus: Real-World Strategies for Addressing a Common Problem. The Journal of family practice, 66(4 Suppl), S46–S51.
Cai, X., Hu, D., Pan, C., Li, G., Lu, J., Ji, Q., Su, B., Tian, H., Qu, S., Weng, J., Zhang, D., Xu, J., & Ji, L. (2019). The risk factors of glycemic control, blood pressure control, lipid control in Chinese patients with newly diagnosed type 2 diabetes _ A nationwide prospective cohort study. Scientific reports, 9(1), 7709. https://doi.org/10.1038/s41598-019-44169-4
Campagna, D., Alamo, A., Di Pino, A., Russo, C., Calogero, A. E., Purrello, F., & Polosa, R. (2019). Smoking and diabetes: dangerous liaisons and confusing relationships. Diabetology & metabolic syndrome, 11, 85. https://doi.org/10.1186/s13098-019-0482-2
Canoy, D., Wareham, N., Luben, R., Welch, A., Bingham, S., Day, N., & Khaw, K. T. (2005). Cigarette smoking and fat distribution in 21,828 British men and women: a population-based study. Obesity research, 13(8), 1466–1475. https://doi.org/10.1038/oby.2005.177
Carreras-Torres, R., Johansson, M., Haycock, P. C., Relton, C. L., Davey Smith, G., Brennan, P., & Martin, R. M. (2018). Role of obesity in smoking behaviour: Mendelian randomisation study in UK Biobank. BMJ (Clinical research ed.), 361, k1767. https://doi.org/10.1136/bmj.k1767
Cersosimo, E., Solis-Herrera, C., Trautmann, M. E., Malloy, J., & Triplitt, C. L. (2014). Assessment of pancreatic β-cell function: review of methods and clinical applications. Current diabetes reviews, 10(1), 2–42. https://doi.org/10.2174/1573399810666140214093600
Chalmers, J., & Cooper, M. E. (2008). UKPDS and the legacy effect. The New England journal of medicine, 359(15), 1618–1620. https://doi.org/10.1056/NEJMe0807625
Chang, A. M., & Halter, J. B. (2003). Aging and insulin secretion. American journal of physiology, endocrinology and metabolism, 284(1), E7–E12. https://doi.org/10.1152/ajpendo.00366.2002
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of chronic diseases, 40(5), 373–383. https://doi.org/10.1016/0021-9681(87)90171-8
Chen, G. D., Huang, C. N., Yang, Y. S., & Lew-Ting, C. Y. (2014). Patient perception of understanding health education and instructions has moderating effect on glycemic control. BMC public health, 14, 683. https://doi.org/10.1186/1471-2458-14-683
Chiolero, A., Faeh, D., Paccaud, F., & Cornuz, J. (2008). Consequences of smoking for body weight, body fat distribution, and insulin resistance. The American journal of clinical nutrition, 87(4), 801–809. https://doi.org/10.1093/ajcn/87.4.801
Chiolero, A., Wietlisbach, V., Ruffieux, C., Paccaud, F., & Cornuz, J. (2006). Clustering of risk behaviors with cigarette consumption: A population-based survey. Preventive medicine, 42(5), 348–353. https://doi.org/10.1016/j.ypmed.2006.01.011
Chiu, C. J., & Wray, L. A. (2010). Factors predicting glycemic control in middle-aged and older adults with type 2 diabetes. Preventing chronic disease, 7(1), A08.
Cho Y. M. (2015). Incretin physiology and pathophysiology from an Asian perspective. Journal of diabetes investigation, 6(5), 495–507. https://doi.org/10.1111/jdi.12305
Chowdhury, P., Rayford, P. L., & Chang, L. W. (1998). Pathophysiological effects of nicotine on the pancreas. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 218(3), 168–173. https://doi.org/10.3181/00379727-218-44284
Chudyk, A., & Petrella, R. J. (2011). Effects of exercise on cardiovascular risk factors in type 2 diabetes: a meta-analysis. 
Diabetes care, 34(5), 1228–1237. https://doi.org/10.2337/dc10-1881
Clair, C., Bitton, A., Meigs, J. B., & Rigotti, N. A. (2011). Relationships of cotinine and self-reported cigarette smoking with hemoglobin A1c in the U.S.: results from the National Health and Nutrition Examination Survey, 1999-2008. Diabetes care, 34(10), 2250–2255. https://doi.org/10.2337/dc11-0710
Colberg, S. R., Sigal, R. J., Yardley, J. E., Riddell, M. C., Dunstan, D. W., Dempsey, P. C., Horton, E. S., Castorino, K., & Tate, D. F. (2016). Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association. Diabetes care, 39(11), 2065–2079. https://doi.org/10.2337/dc16-1728
Cryer, P. E., Haymond, M. W., Santiago, J. V., & Shah, S. D. (1976). Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. The New England journal of medicine, 295(11), 573–577. https://doi.org/10.1056/NEJM197609092951101
Cullen, M. W., Ebbert, J. O., Vierkant, R. A., Wang, A. H., & Cerhan, J. R. (2009). No interaction of body mass index and smoking on diabetes mellitus risk in elderly women. Preventive medicine, 48(1), 74–78. https://doi.org/10.1016/j.ypmed.2008.10.008
Dallosso, H. M., Bodicoat, D. H., Campbell, M., Carey, M. E., Davies, M. J., Eborall, H. C., Hadjiconstantinou, M., Khunti, K., Speight, J., & Heller, S. (2015). Self-monitoring of blood glucose versus self-monitoring of urine glucose in adults with newly diagnosed Type 2 diabetes receiving structured education: a cluster randomized controlled trial. Diabetic medicine, 32(3), 414–422. https://doi.org/10.1111/dme.12598
Davis, W. A., Bruce, D. G., & Davis, T. M. (2007). Does self-monitoring of blood glucose improve outcome in type 2 diabetes? The Fremantle Diabetes Study. Diabetologia, 50(3), 510–515. https://doi.org/10.1007/s00125-006-0581-0
Deng, H., Lin, S., Yang, X., Lv, J., Luo, S., Zeng, L., Weng, J., Xu, W., & CONFIDENCE Group (2019). Effect of baseline body mass index on glycemic control and weight change with exenatide monotherapy in Chinese drug-naïve type 2 diabetic patients. Journal of diabetes, 11(7), 509–518. https://doi.org/10.1111/1753-0407.12883
Derr, R., Garrett, E., Stacy, G. A., & Saudek, C. D. (2003). Is HbA(1c) affected by glycemic instability? Diabetes care, 26(10), 2728–2733. https://doi.org/10.2337/diacare.26.10.2728
Diabetes Control and Complications Trial Research Group, Nathan, D. M., Genuth, S., Lachin, J., Cleary, P., Crofford, O., Davis, M., Rand, L., & Siebert, C. (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The New England journal of medicine, 329(14), 977–986. https://doi.org/10.1056/NEJM199309303291401
Dixon, L. B., Kreyenbuhl, J. A., Dickerson, F. B., Donner, T. W., Brown, C. H., Wohlheiter, K., Postrado, L., Goldberg, R. W., Fang, L., Marano, C., & Messias, E. (2004). A comparison of type 2 diabetes outcomes among persons with and without severe mental illnesses. Psychiatric services (Washington, D.C.), 55(8), 892–900. https://doi.org/10.1176/appi.ps.55.8.892
Doggrell, S. A., & Warot, S. (2014). The association between the measurement of adherence to anti-diabetes medicine and the HbA1c. International journal of clinical pharmacy, 36(3), 488–497. https://doi.org/10.1007/s11096-014-9929-6
Du, Y. F., Ou, H. Y., Beverly, E. A., & Chiu, C. J. (2014). Achieving glycemic control in elderly patients with type 2 diabetes: a critical comparison of current options. Clinical interventions in aging, 9, 1963–1980. https://doi.org/10.2147/CIA.S53482
Duckworth, W. C., Abraira, C., Moritz, T. E., Davis, S. N., Emanuele, N., Goldman, S., Hayward, R., Huang, G. D., Marks, J. B., Reaven, P. D., Reda, D. J., Warren, S. R., Zieve, F. J., & Investigators of the VADT (2011). The duration of diabetes affects the response to intensive glucose control in type 2 subjects: the VA Diabetes Trial. Journal of diabetes and its complications, 25(6), 355–361. https://doi.org/10.1016/j.jdiacomp.2011.10.003
Durán, A., Martín, P., Runkle, I., Pérez, N., Abad, R., Fernández, M., Del Valle, L., Sanz, M. F., & Calle-Pascual, A. L. (2010). Benefits of self-monitoring blood glucose in the management of new-onset Type 2 diabetes mellitus: the St Carlos Study, a prospective randomized clinic-based interventional study with parallel groups. Journal of diabetes, 2(3), 203–211. https://doi.org/10.1111/j.1753-0407.2010.00081.x
Eliasson B. (2003). Cigarette smoking and diabetes. Progress in cardiovascular diseases, 45(5), 405–413. https://doi.org/10.1053/pcad.2003.00103
Eliasson, B., Mero, N., Taskinen, M. R., & Smith, U. (1997). The insulin resistance syndrome and postprandial lipid intolerance in smokers. Atherosclerosis, 129(1), 79–88. https://doi.org/10.1016/s0021-9150(96)06028-5
Eliasson, M., Asplund, K., Evrin, P. E., & Lundblad, D. (1995). Relationship of cigarette smoking and snuff dipping to plasma fibrinogen, fibrinolytic variables and serum insulin. The Northern Sweden MONICA Study. Atherosclerosis, 113(1), 41–53. https://doi.org/10.1016/0021-9150(94)05425-i
El-Kebbi, I. M., Ziemer, D. C., Cook, C. B., Miller, C. D., Gallina, D. L., & Phillips, L. S. (2001). Comorbidity and glycemic control in patients with type 2 diabetes. Archives of internal medicine, 161(10), 1295–1300. https://doi.org/10.1001/archinte.161.10.1295
Epifano, L., Di Vincenzo, A., Fanelli, C., Porcellati, F., Perriello, G., De Feo, P., Motolese, M., Brunetti, P., & Bolli, G. B. (1992). Effect of cigarette smoking and of a transdermal nicotine delivery system on glucoregulation in type 2 diabetes mellitus. European journal of clinical pharmacology, 43(3), 257–263. https://doi.org/10.1007/BF02333019
Facchini, F. S., Hollenbeck, C. B., Jeppesen, J., Chen, Y. D., & Reaven, G. M. (1992). Insulin resistance and cigarette smoking. Lancet (London, England), 339(8802), 1128–1130. https://doi.org/10.1016/0140-6736(92)90730-q
Farmer, A. J., Perera, R., Ward, A., Heneghan, C., Oke, J., Barnett, A. H., Davidson, M. B., Guerci, B., Coates, V., Schwedes, U., & O'Malley, S. (2012). Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes. BMJ (Clinical research ed.), 344, e486. https://doi.org/10.1136/bmj.e486
Farmer, A., Wade, A., Goyder, E., Yudkin, P., French, D., Craven, A., Holman, R., Kinmonth, A. L., & Neil, A. (2007). Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ (Clinical research ed.), 335(7611), 132. https://doi.org/10.1136/bmj.39247.447431.BE
Ferrie, J. E., Virtanen, M., Jokela, M., Madsen, I., Heikkilä, K., Alfredsson, L., Batty, G. D., Bjorner, J. B., Borritz, M., Burr, H., Dragano, N., Elovainio, M., Fransson, E. I., Knutsson, A., Koskenvuo, M., Koskinen, A., Kouvonen, A., Kumari, M., Nielsen, M. L., Nordin, M., … IPD-Work Consortium (2016). Job insecurity and risk of diabetes: a meta-analysis of individual participant data. CMAJ : Canadian Medical Association journal, 188(17-18), E447–E455. https://doi.org/10.1503/cmaj.150942
Flôr, C. R., Baldoni, N. R., Aquino, J. A., Baldoni, A. O., Fabbro, A., Figueiredo, R. C., & Oliveira, C. (2018). What is the association between social capital and diabetes mellitus? A systematic review. Diabetes & metabolic syndrome, 12(4), 601–605. https://doi.org/10.1016/j.dsx.2018.03.021
Franz, M. J., Boucher, J. L., Rutten-Ramos, S., & VanWormer, J. J. (2015). Lifestyle weight-loss intervention outcomes in overweight and obese adults with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials. Journal of the Academy of Nutrition and Dietetics, 115(9), 1447–1463. https://doi.org/10.1016/j.jand.2015.02.031
Franz, M. J., MacLeod, J., Evert, A., Brown, C., Gradwell, E., Handu, D., Reppert, A., & Robinson, M. (2017). Academy of Nutrition and Dietetics Nutrition Practice Guideline for Type 1 and Type 2 Diabetes in Adults: Systematic Review of Evidence for Medical Nutrition Therapy Effectiveness and Recommendations for Integration into the Nutrition Care Process. Journal of the Academy of Nutrition and Dietetics, 117(10), 1659–1679. https://doi.org/10.1016/j.jand.2017.03.022
Frati, A. C., Iniestra, F., & Ariza, C. R. (1996). Acute effect of cigarette smoking on glucose tolerance and other cardiovascular risk factors. Diabetes care, 19(2), 112–118. https://doi.org/10.2337/diacare.19.2.112
Fujita, Y., Fukushima, M., Suzuki, H., Taniguchi, A., Nakai, Y., Kuroe, A., Yasuda, K., Hosokawa, M., Yamada, Y., Inagaki, N., & Seino, Y. (2008). Short-term intensive glycemic control improves vibratory sensation in type 2 diabetes. Diabetes research and clinical practice, 80(1), e16–e19. https://doi.org/10.1016/j.diabres.2007.12.011
Fujiyoshi, A., Miura, K., Kadowaki, S., Azuma, K., Tanaka, S., Hisamatsu, T., Arima, H., Kadota, A., Miyagawa, N., Takashima, N., Ohkubo, T., Saitoh, Y., Torii, S., Miyazawa, I., Maegawa, H., Murata, K., Ueshima, H., & SESSA Research Group (2016). Lifetime cigarette smoking is associated with abdominal obesity in a community-based sample of Japanese men: The Shiga Epidemiological Study of Subclinical Atherosclerosis (SESSA). Preventive medicine reports, 4, 225–232. https://doi.org/10.1016/j.pmedr.2016.06.013
Funk, M., & Taylor, E. L. (2013). Pedometer-based walking interventions for free-living adults with type 2 diabetes: a systematic review. Current diabetes reviews, 9(6), 462–471. https://doi.org/10.2174/15733998113096660084
Gan, Y., Yang, C., Tong, X., Sun, H., Cong, Y., Yin, X., Li, L., Cao, S., Dong, X., Gong, Y., Shi, O., Deng, J., Bi, H., & Lu, Z. (2015). Shift work and diabetes mellitus: a meta-analysis of observational studies. Occupational and environmental medicine, 72(1), 72–78. https://doi.org/10.1136/oemed-2014-102150
García de la Torre, N., Durán, A., Del Valle, L., Fuentes, M., Barca, I., Martín, P., Montañez, C., Perez-Ferre, N., Abad, R., Sanz, F., Galindo, M., Rubio, M. A., & Calle-Pascual, A. L. (2013). Early management of type 2 diabetes based on a SMBG strategy: the way to diabetes regression--the St Carlos study : a 3-year, prospective, randomized, clinic-based, interventional study with parallel groups. Acta diabetologica, 50(4), 607–614. https://doi.org/10.1007/s00592-013-0467-9
Gaskin, D. J., Thorpe, R. J., Jr, McGinty, E. E., Bower, K., Rohde, C., Young, J. H., LaVeist, T. A., & Dubay, L. (2014). Disparities in diabetes: the nexus of race, poverty, and place. American journal of public health, 104(11), 2147–2155. https://doi.org/10.2105/AJPH.2013.301420
Gebreab, S. Y., Hickson, D. A., Sims, M., Wyatt, S. B., Davis, S. K., Correa, A., & Diez-Roux, A. V. (2017). Neighborhood social and physical environments and type 2 diabetes mellitus in African Americans: The Jackson Heart Study. Health & place, 43, 128–137. https://doi.org/10.1016/j.healthplace.2016.12.001
Geloneze, B., de Oliveira, M., Vasques, A. C., Novaes, F. S., Pareja, J. C., & Tambascia, M. A. (2014). Impaired incretin secretion and pancreatic dysfunction with older age and diabetes. Metabolism: clinical and experimental, 63(7), 922–929. https://doi.org/10.1016/j.metabol.2014.04.004
Giugliano, D., Maiorino, M. I., Bellastella, G., & Esposito, K. (2018). Glycemic control in type 2 diabetes: from medication nonadherence to residual vascular risk. Endocrine, 61(1), 23–27. https://doi.org/10.1007/s12020-017-1517-9
Glasgow, R. E., Hampson, S. E., Strycker, L. A., & Ruggiero, L. (1997). Personal-model beliefs and social-environmental barriers related to diabetes self-management. Diabetes care, 20(4), 556–561. https://doi.org/10.2337/diacare.20.4.556
Gonçalves, R. B., Coletta, R. D., Silvério, K. G., Benevides, L., Casati, M. Z., da Silva, J. S., & Nociti, F. H., Jr (2011). Impact of smoking on inflammation: overview of molecular mechanisms. Inflammation research, 60(5), 409–424. https://doi.org/10.1007/s00011-011-0308-7
Grace, A., Chan, E., Giallauria, F., Graham, P. L., & Smart, N. A. (2017). Clinical outcomes and glycaemic responses to different aerobic exercise training intensities in type II diabetes: a systematic review and meta-analysis. Cardiovascular diabetology, 16(1), 37. https://doi.org/10.1186/s12933-017-0518-6
Grassi, G., Seravalle, G., Calhoun, D. A., Bolla, G. B., Giannattasio, C., Marabini, M., Del Bo, A., & Mancia, G. (1994). Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation, 90(1), 248–253. https://doi.org/10.1161/01.cir.90.1.248
Greenfield, S., Billimek, J., Pellegrini, F., Franciosi, M., De Berardis, G., Nicolucci, A., & Kaplan, S. H. (2009). Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study. Annals of internal medicine, 151(12), 854–860. https://doi.org/10.7326/0003-4819-151-12-200912150-00005
Hallberg, S. J., McKenzie, A. L., Williams, P. T., Bhanpuri, N. H., Peters, A. L., Campbell, W. W., Hazbun, T. L., Volk, B. M., McCarter, J. P., Phinney, S. D., & Volek, J. S. (2018). Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study. Diabetes therapy : research, treatment and education of diabetes and related disorders, 9(2), 583–612. https://doi.org/10.1007/s13300-018-0373-9
Hamdy, O., Mottalib, A., Morsi, A., El-Sayed, N., Goebel-Fabbri, A., Arathuzik, G., Shahar, J., Kirpitch, A., & Zrebiec, J. (2017). Long-term effect of intensive lifestyle intervention on cardiovascular risk factors in patients with diabetes in real-world clinical practice: a 5-year longitudinal study. BMJ open diabetes research & care, 5(1), e000259. https://doi.org/10.1136/bmjdrc-2016-000259
Hameed, E. K., & AbdulQahar, Z. H. (2019). Visceral adiposity index in female with type 2 diabetic mellitus and its association with the glycemic control. Diabetes & metabolic syndrome, 13(2), 1241–1244. https://doi.org/10.1016/j.dsx.2019.01.039
Hartz, J. C., de Ferranti, S., & Gidding, S. (2018). Hypertriglyceridemia in Diabetes Mellitus: Implications for Pediatric Care. Journal of the Endocrine Society, 2(6), 497–512. https://doi.org/10.1210/js.2018-00079
Hautanen, A., & Adlercreutz, H. (1993). Hyperinsulinaemia, dyslipidaemia and exaggerated adrenal androgen response to adrenocorticotropin in male smokers. Diabetologia, 36(12), 1275–1281. https://doi.org/10.1007/BF00400805
Hayashino, Y., Jackson, J. L., Fukumori, N., Nakamura, F., & Fukuhara, S. (2012). Effects of supervised exercise on lipid profiles and blood pressure control in people with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Diabetes research and clinical practice, 98(3), 349–360. https://doi.org/10.1016/j.diabres.2012.10.004
Hellman, R., Regan, J., & Rosen, H. (1997). Effect of intensive treatment of diabetes of the risk of death or renal failure in NIDDM and IDDM. Diabetes care, 20(3), 258–264. https://doi.org/10.2337/diacare.20.3.258
Herman, W. H., & Cohen, R. M. (2012). Racial and ethnic differences in the relationship between HbA1c and blood glucose: implications for the diagnosis of diabetes. The Journal of clinical endocrinology and metabolism, 97(4), 1067–1072. https://doi.org/10.1210/jc.2011-1894
Hertroijs, D., Elissen, A., Brouwers, M., Schaper, N. C., Köhler, S., Popa, M. C., Asteriadis, S., Hendriks, S. H., Bilo, H. J., & Ruwaard, D. (2018). A risk score including body mass index, glycated haemoglobin and triglycerides predicts future glycaemic control in people with type 2 diabetes. Diabetes, obesity & metabolism, 20(3), 681–688. https://doi.org/10.1111/dom.13148
Higgins, T., Cembrowski, G., Tran, D., Lim, E., & Chan, J. (2009). Influence of variables on hemoglobin A1c values and nonheterogeneity of hemoglobin A1c reference ranges. Journal of diabetes science and technology, 3(4), 644–648. https://doi.org/10.1177/193229680900300404
Hill-Briggs, F., Adler, N. E., Berkowitz, S. A., Chin, M. H., Gary-Webb, T. L., Navas-Acien, A., Thornton, P. L., & Haire-Joshu, D. (2020). Social Determinants of Health and Diabetes: A Scientific Review. Diabetes care, 44(1), 258–279. Advance online publication. https://doi.org/10.2337/dci20-0053
Hiscock, R., Bauld, L., Amos, A., Fidler, J. A., & Munafò, M. (2012). Socioeconomic status and smoking: a review. Annals of the New York Academy of Sciences, 1248, 107–123. https://doi.org/10.1111/j.1749-6632.2011.06202.x
Holman R. R. (1998). Assessing the potential for alpha-glucosidase inhibitors in prediabetic states. Diabetes research and clinical practice, 40 Suppl, S21–S25. https://doi.org/10.1016/s0168-8227(98)00038-2
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. (2008). 10-year follow-up of intensive glucose control in type 2 diabetes. The New England journal of medicine, 359(15), 1577–1589. https://doi.org/10.1056/NEJMoa0806470
Hou, Y. Y., Li, W., Qiu, J. B., & Wang, X. H. (2014). Efficacy of blood glucose self-monitoring on glycemic control in patients with non-insulin-treated type 2 diabetes: A meta-analysis. International Journal of Nursing Sciences, 1(2), 191–195. https://doi.org/10.1016/j.ijnss.2014.05.003
Hu, F. B., Manson, J. E., Stampfer, M. J., Colditz, G., Liu, S., Solomon, C. G., & Willett, W. C. (2001). Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. The New England journal of medicine, 345(11), 790–797. https://doi.org/10.1056/NEJMoa010492
Huang, J. H., Li, R. H., Huang, S. L., Sia, H. K., Chen, Y. L., & Tang, F. C. (2015). Lifestyle Factors and Metabolic Syndrome among Workers: The Role of Interactions between Smoking and Alcohol to Nutrition and Exercise. International journal of environmental research and public health, 12(12), 15967–15978. https://doi.org/10.3390/ijerph121215035
International Diabetes Federation. (2017). Guideline on self-monitoring of blood glucose in non-insulin treated type 2 diabetes [Internet]. 2017 Nov 4. Available from: https://www.idf.org/e-library/guidelines/85-self-monitoring-of-blood-glucose-in-non-insulin-treated-type-2-diabetes.html. Accessed 2020 Aug 23.
Janzon, L., Berntorp, K., Hanson, M., Lindell, S. E., & Trell, E. (1983). Glucose tolerance and smoking: a population study of oral and intravenous glucose tolerance tests in middle-aged men. Diabetologia, 25(2), 86–88. https://doi.org/10.1007/BF00250893
Jee, S. H., Foong, A. W., Hur, N. W., & Samet, J. M. (2010). Smoking and risk for diabetes incidence and mortality in Korean men and women. Diabetes care, 33(12), 2567–2572. https://doi.org/10.2337/dc10-0261
Jensen, C. C., Cnop, M., Hull, R. L., Fujimoto, W. Y., Kahn, S. E., & American Diabetes Association GENNID Study Group (2002). Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S. Diabetes, 51(7), 2170–2178. https://doi.org/10.2337/diabetes.51.7.2170
Jensen, M. H., Cichosz, S. L., Hirsch, I. B., Vestergaard, P., Hejlesen, O., & Seto, E. (2020). Smoking is Associated With Increased Risk of Not Achieving Glycemic Target, Increased Glycemic Variability, and Increased Risk of Hypoglycemia for People With Type 1 Diabetes. Journal of diabetes science and technology, 1932296820922254. Advance online publication. https://doi.org/10.1177/1932296820922254
Ji, L., Li, H., Guo, X., Li, Y., Hu, R., & Zhu, Z. (2013). Impact of baseline BMI on glycemic control and weight change with metformin monotherapy in Chinese type 2 diabetes patients: phase IV open-label trial. PloS one, 8(2), e57222. https://doi.org/10.1371/journal.pone.0057222
Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014). Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet (London, England), 383(9922), 1068–1083. https://doi.org/10.1016/S0140-6736(13)62154-6
Karter, A. J., Parker, M. M., Moffet, H. H., Ahmed, A. T., Ferrara, A., Liu, J. Y., & Selby, J. V. (2004). Missed appointments and poor glycemic control: an opportunity to identify high-risk diabetic patients. Medical care, 42(2), 110–115. https://doi.org/10.1097/01.mlr.0000109023.64650.73
Karter, A. J., Parker, M. M., Moffet, H. H., Spence, M. M., Chan, J., Ettner, S. L., & Selby, J. V. (2006). Longitudinal study of new and prevalent use of self-monitoring of blood glucose. Diabetes care, 29(8), 1757–1763. https://doi.org/10.2337/dc06-2073
Kavaric, N., Klisic, A., & Ninic, A. (2018). Are visceral adiposity index and lipid accumulation product reliable indices for metabolic disturbances in patients with type 2 diabetes mellitus?. Journal of clinical laboratory analysis, 32(3), e22283. https://doi.org/10.1002/jcla.22283
Kazemian, P., Shebl, F. M., McCann, N., Walensky, R. P., & Wexler, D. J. (2019). Evaluation of the Cascade of Diabetes Care in the United States, 2005-2016. JAMA internal medicine, 179(10), 1376–1385. Advance online publication. https://doi.org/10.1001/jamainternmed.2019.2396
Khan, H. A., Sobki, S. H., & Khan, S. A. (2007). Association between glycaemic control and serum lipids profile in type 2 diabetic patients: HbA1c predicts dyslipidaemia. Clinical and experimental medicine, 7(1), 24–29. https://doi.org/10.1007/s10238-007-0121-3
Kim, D., Choy, Y. S., & Park, E. C. (2017). Association between secondhand smoke and glycemic control in adult diabetes patients. Preventive medicine, 94, 48–54. https://doi.org/10.1016/j.ypmed.2016.11.009
Kim, J. H., Shim, K. W., Yoon, Y. S., Lee, S. Y., Kim, S. S., & Oh, S. W. (2012). Cigarette smoking increases abdominal and visceral obesity but not overall fatness: an observational study. PloS one, 7(9), e45815. https://doi.org/10.1371/journal.pone.0045815
Kirkman, M. S., Briscoe, V. J., Clark, N., Florez, H., Haas, L. B., Halter, J. B., Huang, E. S., Korytkowski, M. T., Munshi, M. N., Odegard, P. S., Pratley, R. E., Swift, C. S., & Consensus Development Conference on Diabetes and Older Adults (2012). Diabetes in older adults: a consensus report. Journal of the American Geriatrics Society, 60(12), 2342–2356. https://doi.org/10.1111/jgs.12035
Komiya, H., Mori, Y., Yokose, T., & Tajima, N. (2006). Smoking as a risk factor for visceral fat accumulation in Japanese men. The Tohoku journal of experimental medicine, 208(2), 123–132. https://doi.org/10.1620/tjem.208.123
Krapek, K., King, K., Warren, S. S., George, K. G., Caputo, D. A., Mihelich, K., Holst, E. M., Nichol, M. B., Shi, S. G., Livengood, K. B., Walden, S., & Lubowski, T. J. (2004). Medication adherence and associated hemoglobin A1c in type 2 diabetes. The Annals of pharmacotherapy, 38(9), 1357–1362. https://doi.org/10.1345/aph.1D612
Krass, I., Schieback, P., & Dhippayom, T. (2015). Adherence to diabetes medication: a systematic review. Diabetic medicine : a journal of the British Diabetic Association, 32(6), 725–737. https://doi.org/10.1111/dme.12651
Lager I. (1991). The insulin-antagonistic effect of the counterregulatory hormones. Journal of internal medicine. Supplement, 735, 41–47.
Laiteerapong, N., Ham, S. A., Gao, Y., Moffet, H. H., Liu, J. Y., Huang, E. S., & Karter, A. J. (2019). The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study). Diabetes care, 42(3), 416–426. https://doi.org/10.2337/dc17-1144
Leahy, J. L., Hirsch, I. B., Peterson, K. A., & Schneider, D. (2010). Targeting beta-cell function early in the course of therapy for type 2 diabetes mellitus. The Journal of clinical endocrinology and metabolism, 95(9), 4206–4216. https://doi.org/10.1210/jc.2010-0668
Lean, M. E., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., Rodrigues, A. M., Rehackova, L., Adamson, A. J., Sniehotta, F. F., Mathers, J. C., Ross, H. M., McIlvenna, Y., Stefanetti, R., Trenell, M., Welsh, P., … Taylor, R. (2018). Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet (London, England), 391(10120), 541–551. https://doi.org/10.1016/S0140-6736(17)33102-1
Levey, A. S., Coresh, J., Balk, E., Kausz, A. T., Levin, A., Steffes, M. W., Hogg, R. J., Perrone, R. D., Lau, J., Eknoyan, G., & National Kidney Foundation (2003). National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Annals of internal medicine, 139(2), 137–147. https://doi.org/10.7326/0003-4819-139-2-200307150-00013
Ley, S. H., Hamdy, O., Mohan, V., & Hu, F. B. (2014). Prevention and management of type 2 diabetes: dietary components and nutritional strategies. Lancet (London, England), 383(9933), 1999–2007. https://doi.org/10.1016/S0140-6736(14)60613-9
Liese, A. D., Ma, X., Reid, L., Sutherland, M. W., Bell, B. A., Eberth, J. M., Probst, J. C., Turley, C. B., & Mayer-Davis, E. J. (2019). Health care access and glycemic control in youth and young adults with type 1 and type 2 diabetes in South Carolina. Pediatric diabetes, 20(3), 321–329. https://doi.org/10.1111/pedi.12822
Little, R. R., Rohlfing, C. L., Sacks, D. B., & National Glycohemoglobin Standardization Program (NGSP) Steering Committee (2011). Status of hemoglobin A1c measurement and goals for improvement: from chaos to order for improving diabetes care. Clinical chemistry, 57(2), 205–214. https://doi.org/10.1373/clinchem.2010.148841
Liu, X., Bragg, F., Yang, L., Kartsonaki, C., Guo, Y., Du, H., Bian, Z., Chen, Y., Yu, C., Lv, J., Wang, K., Zhang, H., Chen, J., Clarke, R., Collins, R., Peto, R., Li, L., Chen, Z., & China Kadoorie Biobank Collaborative Group (2018). Smoking and smoking cessation in relation to risk of diabetes in Chinese men and women: a 9-year prospective study of 0·5 million people. The Lancet. Public health, 3(4), e167–e176. https://doi.org/10.1016/S2468-2667(18)30026-4
Lohse, T., Rohrmann, S., Bopp, M., & Faeh, D. (2016). Heavy Smoking Is More Strongly Associated with General Unhealthy Lifestyle than Obesity and Underweight. PloS one, 11(2), e0148563. https://doi.org/10.1371/journal.pone.0148563
Ma, R. C., & Chan, J. C. (2013). Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States. Annals of the New York Academy of Sciences, 1281(1), 64–91. https://doi.org/10.1111/nyas.12098
Machry, R. V., Rados, D. V., Gregório, G. R., & Rodrigues, T. C. (2018). Self-monitoring blood glucose improves glycemic control in type 2 diabetes without intensive treatment: A systematic review and meta-analysis. Diabetes research and clinical practice, 142, 173–187. https://doi.org/10.1016/j.diabres.2018.05.037
Mackenbach, J. P., Kulhánová, I., Bopp, M., Deboosere, P., Eikemo, T. A., Hoffmann, R., Kulik, M. C., Leinsalu, M., Martikainen, P., Menvielle, G., Regidor, E., Wojtyniak, B., Östergren, O., Lundberg, O., & EURO-GBD-SE Consortium (2015). Variations in the relation between education and cause-specific mortality in 19 European populations: a test of the "fundamental causes" theory of social inequalities in health. Social science & medicine (1982), 127, 51–62. https://doi.org/10.1016/j.socscimed.2014.05.021
MacLeod, J., Franz, M. J., Handu, D., Gradwell, E., Brown, C., Evert, A., Reppert, A., & Robinson, M. (2017). Academy of Nutrition and Dietetics Nutrition Practice Guideline for Type 1 and Type 2 Diabetes in Adults: Nutrition Intervention Evidence Reviews and Recommendations. Journal of the Academy of Nutrition and Dietetics, 117(10), 1637–1658. https://doi.org/10.1016/j.jand.2017.03.023
Maddatu, J., Anderson-Baucum, E., & Evans-Molina, C. (2017). Smoking and the risk of type 2 diabetes. Translational Research, 184, 101–107. https://doi.org/10.1016/j.trsl.2017.02.004
Malanda, U. L., Welschen, L. M., Riphagen, I. I., Dekker, J. M., Nijpels, G., & Bot, S. D. (2012). Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin. The Cochrane database of systematic reviews, 1, CD005060. https://doi.org/10.1002/14651858.CD005060.pub3
Mannucci, E., Antenore, A., Giorgino, F., & Scavini, M. (2018). Effects of Structured Versus Unstructured Self-Monitoring of Blood Glucose on Glucose Control in Patients With Non-insulin-treated Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials. Journal of diabetes science and technology, 12(1), 183–189. https://doi.org/10.1177/1932296817719290
Manodpitipong, A., Saetung, S., Nimitphong, H., Siwasaranond, N., Wongphan, T., Sornsiriwong, C., Luckanajantachote, P., Mangjit, P., Keesukphan, P., Crowley, S. J., Hood, M. M., & Reutrakul, S. (2017). Night-shift work is associated with poorer glycaemic control in patients with type 2 diabetes. Journal of sleep research, 26(6), 764–772. https://doi.org/10.1111/jsr.12554
Marciano, L., Camerini, A. L., & Schulz, P. J. (2019). The Role of Health Literacy in Diabetes Knowledge, Self-Care, and Glycemic Control: a Meta-analysis. Journal of general internal medicine, 34(6), 1007–1017. https://doi.org/10.1007/s11606-019-04832-y
Martin, S., Schneider, B., Heinemann, L., Lodwig, V., Kurth, H. J., Kolb, H., & Scherbaum, W. A. (2006). Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia, 49(2), 271–278. https://doi.org/10.1007/s00125-005-0083-5
Martono, D. P., Lub, R., Lambers Heerspink, H. J., Hak, E., Wilffert, B., & Denig, P. (2015). Predictors of response in initial users of metformin and sulphonylurea derivatives: a systematic review. Diabetic medicine : a journal of the British Diabetic Association, 32(7), 853–864. https://doi.org/10.1111/dme.12688
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28(7), 412–419. https://doi.org/10.1007/BF00280883
Matthews, D. R., Paldánius, P. M., Proot, P., Chiang, Y., Stumvoll, M., Del Prato, S., & VERIFY study group (2019). Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial. Lancet (London, England), 394(10208), 1519–1529. https://doi.org/10.1016/S0140-6736(19)32131-2
McCoy, R. G., Lipska, K. J., Van Houten, H. K., & Shah, N. D. (2020). Paradox of glycemic management: multimorbidity, glycemic control, and high-risk medication use among adults with diabetes. BMJ open diabetes research & care, 8(1), e001007. https://doi.org/10.1136/bmjdrc-2019-001007
McCoy, R. G., Ngufor, C., Van Houten, H. K., Caffo, B., & Shah, N. D. (2017). Trajectories of Glycemic Change in a National Cohort of Adults With Previously Controlled Type 2 Diabetes. Medical care, 55(11), 956–964. https://doi.org/10.1097/MLR.0000000000000807
Meier, J. L., Swislocki, A. L., Lopez, J. R., Noth, R. H., Bartlebaugh, P., & Siegel, D. (2002). Reduction in self-monitoring of blood glucose in persons with type 2 diabetes results in cost savings and no change in glycemic control. The American journal of managed care, 8(6), 557–565.
Michnovicz, J. J., Hershcopf, R. J., Naganuma, H., Bradlow, H. L., & Fishman, J. (1986). Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. The New England journal of medicine, 315(21), 1305–1309. https://doi.org/10.1056/NEJM198611203152101
Mondesir, F. L., White, K., Liese, A. D., & McLain, A. C. (2016). Gender, Illness-Related Diabetes Social Support, and Glycemic Control Among Middle-Aged and Older Adults. The journals of gerontology. Series B, Psychological sciences and social sciences, 71(6), 1081–1088. https://doi.org/10.1093/geronb/gbv061
Monnier, L., & Colette, C. (2006). Contributions of fasting and postprandial glucose to hemoglobin A1c. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 12 Suppl 1, 42–46. https://doi.org/10.4158/EP.12.S1.42
Moon, J., Kim, J. Y., Yoo, S., & Koh, G. (2020). Fasting and Postprandial Hyperglycemia: Their Predictors and Contributions to Overall Hyperglycemia in Korean Patients with Type 2 Diabetes. Endocrinology and metabolism (Seoul, Korea), 35(2), 290–297. https://doi.org/10.3803/EnM.2020.35.2.290
Morimoto, A., Tatsumi, Y., Deura, K., Mizuno, S., Ohno, Y., & Watanabe, S. (2013). Impact of cigarette smoking on impaired insulin secretion and insulin resistance in Japanese men: The Saku Study. Journal of diabetes investigation, 4(3), 274–280. https://doi.org/10.1111/jdi.12019
Morkos, M., Tahsin, B., & Fogelfeld, L. (2020). Factors Associated with Diabetes Control in Predominately African American and Hispanic Population with Newly Diagnosed Type 2 Diabetes. Journal of racial and ethnic health disparities, 10.1007/s40615-020-00785-9. Advance online publication. https://doi.org/10.1007/s40615-020-00785-9
Morris, R. W., Taylor, A. E., Fluharty, M. E., Bjørngaard, J. H., Åsvold, B. O., Elvestad Gabrielsen, M., Campbell, A., Marioni, R., Kumari, M., Korhonen, T., Männistö, S., Marques-Vidal, P., Kaakinen, M., Cavadino, A., Postmus, I., Husemoen, L. L., Skaaby, T., Ahluwalia, T. V., Treur, J. L., Willemsen, G., … Sattar, N. (2015). Heavier smoking may lead to a relative increase in waist circumference: evidence for a causal relationship from a Mendelian randomisation meta-analysis. The CARTA consortium. BMJ open, 5(8), e008808. https://doi.org/10.1136/bmjopen-2015-008808
Morrow, J. D., Frei, B., Longmire, A. W., Gaziano, J. M., Lynch, S. M., Shyr, Y., Strauss, W. E., Oates, J. A., & Roberts, L. J., 2nd (1995). Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. The New England journal of medicine, 332(18), 1198–1203. https://doi.org/10.1056/NEJM199505043321804
Mozaffarian, D., Kamineni, A., Carnethon, M., Djoussé, L., Mukamal, K. J., & Siscovick, D. (2009). Lifestyle risk factors and new-onset diabetes mellitus in older adults: the cardiovascular health study. Archives of internal medicine, 169(8), 798–807. https://doi.org/10.1001/archinternmed.2009.21
Mullugeta, Y., Chawla, R., Kebede, T., & Worku, Y. (2012). Dyslipidemia associated with poor glycemic control in type 2 diabetes mellitus and the protective effect of metformin supplementation. Indian journal of clinical biochemistry : IJCB, 27(4), 363–369. https://doi.org/10.1007/s12291-012-0225-8
Nagaya, T., Yoshida, H., Takahashi, H., & Kawai, M. (2008). Heavy smoking raises risk for type 2 diabetes mellitus in obese men; but, light smoking reduces the risk in lean men: a follow-up study in Japan. Annals of epidemiology, 18(2), 113–118. https://doi.org/10.1016/j.annepidem.2007.07.107
Nakanishi, N., Nakamura, K., Matsuo, Y., Suzuki, K., & Tatara, K. (2000). Cigarette smoking and risk for impaired fasting glucose and type 2 diabetes in middle-aged Japanese men. Annals of internal medicine, 133(3), 183–191. https://doi.org/10.7326/0003-4819-133-3-200008010-00009
Narkiewicz, K., van de Borne, P. J., Hausberg, M., Cooley, R. L., Winniford, M. D., Davison, D. E., & Somers, V. K. (1998). Cigarette smoking increases sympathetic outflow in humans. Circulation, 98(6), 528–534. https://doi.org/10.1161/01.cir.98.6.528
Nathan, D. M., Kuenen, J., Borg, R., Zheng, H., Schoenfeld, D., Heine, R. J., & A1c-Derived Average Glucose Study Group (2008). Translating the A1C assay into estimated average glucose values. Diabetes care, 31(8), 1473–1478. https://doi.org/10.2337/dc08-0545
National Institute for Health and Care Excellence. (2019). 2019 surveillance of Type 2 diabetes in adults: management (2015) NICE guideline NG28. Appendix A2: Summary of evidence from surveillance [Internet]. 2019 Jun 27. Available from: https://www.nice.org.uk/guidance/ng17/evidence/appendix-a2-summary-of-evidence-from-surveillance-ng28-pdf-6837997936. Accessed 2020 Aug 23.
Nichols, G. A., Conner, C., & Brown, J. B. (2010). Initial nonadherence, primary failure and therapeutic success of metformin monotherapy in clinical practice. Current medical research and opinion, 26(9), 2127–2135. https://doi.org/10.1185/03007995.2010.504396
Nilsson, P. M., Gudbjörnsdottir, S., Eliasson, B., Cederholm, J., & Steering Committee of the Swedish National Diabetes Register (2004). Smoking is associated with increased HbA1c values and microalbuminuria in patients with diabetes--data from the National Diabetes Register in Sweden. Diabetes & metabolism, 30(3), 261–268. https://doi.org/10.1016/s1262-3636(07)70117-9
Ning, F., Qiao, Q., Tuomilehto, J., Hammar, N., Ho, S. Y., Söderberg, S., Zimmet, P. Z., Shaw, J. E., Nakagami, T., Mohan, V., Ramachandran, A., Lam, T. H., Andersson, S. W., Janus, E. D., Boyko, E. J., Fujimoto, W. Y., Pang, Z. C., & DECODA Study Group (2010). Does abnormal insulin action or insulin secretion explain the increase in prevalence of impaired glucose metabolism with age in populations of different ethnicities?. Diabetes/metabolism research and reviews, 26(4), 245–253. https://doi.org/10.1002/dmrr.1078
Noma, K., Goto, C., Nishioka, K., Hara, K., Kimura, M., Umemura, T., Jitsuiki, D., Nakagawa, K., Oshima, T., Chayama, K., Yoshizumi, M., & Higashi, Y. (2005). Smoking, endothelial function, and Rho-kinase in humans. Arteriosclerosis, thrombosis, and vascular biology, 25(12), 2630–2635. https://doi.org/10.1161/01.ATV.0000189304.32725.bd
Norris, S. L., Lau, J., Smith, S. J., Schmid, C. H., & Engelgau, M. M. (2002). Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes care, 25(7), 1159–1171. https://doi.org/10.2337/diacare.25.7.1159
Ohkuma, T., Iwase, M., Fujii, H., Kaizu, S., Ide, H., Jodai, T., Kikuchi, Y., Idewaki, Y., Hirakawa, Y., Nakamura, U., & Kitazono, T. (2015). Dose- and time-dependent association of smoking and its cessation with glycemic control and insulin resistance in male patients with type 2 diabetes mellitus: the Fukuoka Diabetes Registry. PloS one, 10(3), e0122023. https://doi.org/10.1371/journal.pone.0122023
O'Kane, M. J., Bunting, B., Copeland, M., Coates, V. E., & ESMON study group (2008). Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ (Clinical research ed.), 336(7654), 1174–1177. https://doi.org/10.1136/bmj.39534.571644.BE
Ostgren, C. J., Lindblad, U., Ranstam, J., Melander, A., Råstam, L., & Skaraborg Hypertension and Diabetes Project (2000). Associations between smoking and beta-cell function in a non-hypertensive and non-diabetic population. Skaraborg Hypertension and Diabetes Project. Diabetic medicine : a journal of the British Diabetic Association, 17(6), 445–450. https://doi.org/10.1046/j.1464-5491.2000.00294.x
Pan, A., Wang, Y., Talaei, M., Hu, F. B., & Wu, T. (2015). Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis. The lancet. Diabetes & endocrinology, 3(12), 958–967. https://doi.org/10.1016/S2213-8587(15)00316-2
Pang, J., Chan, D. C., & Watts, G. F. (2014). Origin and therapy for hypertriglyceridaemia in type 2 diabetes. World journal of diabetes, 5(2), 165–175. https://doi.org/10.4239/wjd.v5.i2.165
Parsons SN, Luzio SD, Harvey JN, Bain SC, Cheung WY, Watkins A, et al. (2019) Effect of structured self-monitoring of blood glucose, with and without additional TeleCare support, on overall glycaemic control in non-insulin treated Type 2 diabetes: the SMBG Study, a 12-month randomized controlled trial. Diabetic Medicine 17:17
Patja, K., Jousilahti, P., Hu, G., Valle, T., Qiao, Q., & Tuomilehto, J. (2005). Effects of smoking, obesity and physical activity on the risk of type 2 diabetes in middle-aged Finnish men and women. Journal of internal medicine, 258(4), 356–362. https://doi.org/10.1111/j.1365-2796.2005.01545.x
Peng, K., Chen, G., Liu, C., Mu, Y., Ye, Z., Shi, L., Zhao, J., Chen, L., Li, Q., Yang, T., Yan, L., Wan, Q., Wu, S., Wang, G., Luo, Z., Tang, X., Huo, Y., Gao, Z., Su, Q., Wang, Y., … REACTION Study Group (2018). Association between smoking and glycemic control in diabetic patients: Results from the Risk Evaluation of cAncers in Chinese diabeTic Individuals: A lONgitudinal (REACTION) study. Journal of diabetes, 10(5), 408–418. https://doi.org/10.1111/1753-0407.12625
Physical Activity Guidelines Advisory Committee (2018). 2018 Physical Activity Guidelines Advisory Committee Scientific Report. Washington, DC, U.S. Department of Health and Human Services
Piette, J. D., & Kerr, E. A. (2006). The impact of comorbid chronic conditions on diabetes care. Diabetes care, 29(3), 725–731. https://doi.org/10.2337/diacare.29.03.06.dc05-2078
Polonsky, W. H., & Henry, R. R. (2016). Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient preference and adherence, 10, 1299–1307. https://doi.org/10.2147/PPA.S106821
Polonsky, W. H., Fisher, L., Schikman, C. H., Hinnen, D. A., Parkin, C. G., Jelsovsky, Z., Petersen, B., Schweitzer, M., & Wagner, R. S. (2011). Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study. Diabetes care, 34(2), 262–267. https://doi.org/10.2337/dc10-1732
Poolsup, N., Suksomboon, N., & Rattanasookchit, S. (2009). Meta-analysis of the benefits of self-monitoring of blood glucose on glycemic control in type 2 diabetes patients: an update. Diabetes technology & therapeutics, 11(12), 775–784. https://doi.org/10.1089/dia.2009.0091
Qiu, S., Cai, X., Chen, X., Yang, B., & Sun, Z. (2014). Step counter use in type 2 diabetes: a meta-analysis of randomized controlled trials. BMC medicine, 12, 36. https://doi.org/10.1186/1741-7015-12-36
Qiu, S., Cai, X., Schumann, U., Velders, M., Sun, Z., & Steinacker, J. M. (2014). Impact of walking on glycemic control and other cardiovascular risk factors in type 2 diabetes: a meta-analysis. PloS one, 9(10), e109767. https://doi.org/10.1371/journal.pone.0109767
Ren, Q., Ji, L. N., Lu, J. M., Li, Y. F., Li, Q. M., Lin, S. S., Lv, X. F., Wang, L., Xu, Y., Guo, X. H., Guo, Q. Y., Ma, L., Du, J., Chen, Y. L., Zhao, C. L., Zhang, Q. L., She, Q. M., Jiao, X. M., Lu, M. H., Sun, X. M., … Zhang, J. (2020). Search for clinical predictors of good glycemic control in patients starting or intensifying oral hypoglycemic pharmacological therapy: A multicenter prospective cohort study. Journal of diabetes and its complications, 34(2), 107464. https://doi.org/10.1016/j.jdiacomp.2019.107464
Rimm, E. B., Chan, J., Stampfer, M. J., Colditz, G. A., & Willett, W. C. (1995). Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ (Clinical research ed.), 310(6979), 555–559. https://doi.org/10.1136/bmj.310.6979.555
Rimm, E. B., Manson, J. E., Stampfer, M. J., Colditz, G. A., Willett, W. C., Rosner, B., Hennekens, C. H., & Speizer, F. E. (1993). Cigarette smoking and the risk of diabetes in women. American journal of public health, 83(2), 211–214. https://doi.org/10.2105/ajph.83.2.211
Rohleder, N., & Kirschbaum, C. (2006). The hypothalamic-pituitary-adrenal (HPA) axis in habitual smokers. International journal of psychophysiology : official journal of the International Organization of Psychophysiology, 59(3), 236–243. https://doi.org/10.1016/j.ijpsycho.2005.10.012
Rubin, R. R., Peyrot, M., & Saudek, C. D. (1991). Differential effect of diabetes education on self-regulation and life-style behaviors. Diabetes care, 14(4), 335–338. https://doi.org/10.2337/diacare.14.4.335
Sainsbury, E., Kizirian, N. V., Partridge, S. R., Gill, T., Colagiuri, S., & Gibson, A. A. (2018). Effect of dietary carbohydrate restriction on glycemic control in adults with diabetes: A systematic review and meta-analysis. Diabetes research and clinical practice, 139, 239–252. https://doi.org/10.1016/j.diabres.2018.02.026
Sakai, R., Hashimoto, Y., Ushigome, E., Okamura, T., Hamaguchi, M., Yamazaki, M., Oda, Y., & Fukui, M. (2019). Understanding of antidiabetic medication is associated with blood glucose in patients with type 2 diabetes: At baseline date of the KAMOGAWA-DM cohort study. Journal of diabetes investigation, 10(2), 458–465. https://doi.org/10.1111/jdi.12916
Sakano, N., Wang, D. H., Takahashi, N., Wang, B., Sauriasari, R., Kanbara, S., Sato, Y., Takigawa, T., Takaki, J., & Ogino, K. (2009). Oxidative stress biomarkers and lifestyles in Japanese healthy people. Journal of clinical biochemistry and nutrition, 44(2), 185–195. https://doi.org/10.3164/jcbn.08-252
Sandberg, H., Roman, L., Zavodnick, J., & Kupers, N. (1973). The effect of smoking on serum somatotropin, immunoreactive insulin and blood glucose levels of young adult males. The Journal of pharmacology and experimental therapeutics, 184(3), 787–791.
Sargeant, L. A., Khaw, K. T., Bingham, S., Day, N. E., Luben, R. N., Oakes, S., Welch, A., & Wareham, N. J. (2001). Cigarette smoking and glycaemia: the EPIC-Norfolk Study. European Prospective Investigation into Cancer. International journal of epidemiology, 30(3), 547–554. https://doi.org/10.1093/ije/30.3.547
Saslow, L. R., Daubenmier, J. J., Moskowitz, J. T., Kim, S., Murphy, E. J., Phinney, S. D., Ploutz-Snyder, R., Goldman, V., Cox, R. M., Mason, A. E., Moran, P., & Hecht, F. M. (2017). Twelve-month outcomes of a randomized trial of a moderate-carbohydrate versus very low-carbohydrate diet in overweight adults with type 2 diabetes mellitus or prediabetes. Nutrition & diabetes, 7(12), 304. https://doi.org/10.1038/s41387-017-0006-9
Savin, Z., Kivity, S., Yonath, H., & Yehuda, S. (2018). Smoking and the intestinal microbiome. Archives of microbiology, 200(5), 677–684. https://doi.org/10.1007/s00203-018-1506-2
Saydah, S., & Lochner, K. (2010). Socioeconomic status and risk of diabetes-related mortality in the U.S. Public health reports (Washington, D.C. : 1974), 125(3), 377–388. https://doi.org/10.1177/003335491012500306
Scheen A. J. (2005). Diabetes mellitus in the elderly: insulin resistance and/or impaired insulin secretion?. Diabetes & metabolism, 31 Spec No 2, 5S27–5S34. https://doi.org/10.1016/s1262-3636(05)73649-1
Schnell, O., Alawi, H., Battelino, T., Ceriello, A., Diem, P., Felton, A. M., Grzeszczak, W., Harno, K., Kempler, P., Satman, I., & Vergès, B. (2013). Self-monitoring of blood glucose in type 2 diabetes: recent studies. Journal of diabetes science and technology, 7(2), 478–488. https://doi.org/10.1177/193229681300700225
Schütt, M., Zimmermann, A., Hood, R., Hummel, M., Seufert, J., Siegel, E., Tytko, A., Holl, R. W., DPV initiative, & German BMBF Competence Network Diabetes Mellitus (2015). Gender-specific Effects of Treatment with Lifestyle, Metformin or Sulfonylurea on Glycemic Control and Body Weight: A German Multicenter Analysis on 9 108 Patients. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 123(10), 622–626. https://doi.org/10.1055/s-0035-1559608
Schwedes, U., Siebolds, M., Mertes, G., & SMBG Study Group (2002). Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients. Diabetes care, 25(11), 1928–1932. https://doi.org/10.2337/diacare.25.11.1928
Schwingshackl, L., Missbach, B., Dias, S., König, J., & Hoffmann, G. (2014). Impact of different training modalities on glycaemic control and blood lipids in patients with type 2 diabetes: a systematic review and network meta-analysis. Diabetologia, 57(9), 1789–1797. https://doi.org/10.1007/s00125-014-3303-z
Scott, G., Ramos-Pérez, N., Ramos-Estremera, N., Mirles-Muñiz, I., Padilla-Diffoot, A., Ramos-Lucca, A., Asencio-Toro, G., & Jiménez-Chávez, J. (2020). Relating sociodemographic factors and glycemic control among inpatients with type 2 diabetes. Journal of Public Health: From Theory to Practice. https://doi.org/10.1007/s10389-020-01303-1
Seet, R. C., Loke, W. M., Khoo, C. M., Chew, S. E., Chong, W. L., Quek, A. M., Lim, E. C., & Halliwell, B. (2012). Acute effects of cigarette smoking on insulin resistance and arterial stiffness in young adults. Atherosclerosis, 224(1), 195–200. https://doi.org/10.1016/j.atherosclerosis.2012.06.060
Seino, Y., & Yabe, D. (2013). Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas. Journal of diabetes investigation, 4(2), 108–130. https://doi.org/10.1111/jdi.12065
Shahwan, M. J., Jairoun, A. A., Farajallah, A., & Shanabli, S. (2019). Prevalence of dyslipidemia and factors affecting lipid profile in patients with type 2 diabetes. Diabetes & metabolic syndrome, 13(4), 2387–2392. https://doi.org/10.1016/j.dsx.2019.06.009
Sheen, Y. J., Hsu, C. C., Jiang, Y. D., Huang, C. N., Liu, J. S., & Sheu, W. H. (2019). Trends in prevalence and incidence of diabetes mellitus from 2005 to 2014 in Taiwan. Journal of the Formosan Medical Association, 118 Suppl 2, S66–S73. https://doi.org/10.1016/j.jfma.2019.06.016
Shi, L., Shu, X. O., Li, H., Cai, H., Liu, Q., Zheng, W., Xiang, Y. B., & Villegas, R. (2013). Physical activity, smoking, and alcohol consumption in association with incidence of type 2 diabetes among middle-aged and elderly Chinese men. PloS one, 8(11), e77919. https://doi.org/10.1371/journal.pone.0077919
Śliwińska-Mossoń, M., & Milnerowicz, H. (2017). The impact of smoking on the development of diabetes and its complications. Diabetes & vascular disease research, 14(4), 265–276. https://doi.org/10.1177/1479164117701876
Smith, R. J., Koenig, R. J., Binnerts, A., Soeldner, J. S., & Aoki, T. T. (1982). Regulation of hemoglobin AIc formation in human erythrocytes in vitro. Effects of physiologic factors other than glucose. The Journal of clinical investigation, 69(5), 1164–1168. https://doi.org/10.1172/jci110552
Sodipo, O. O., Adedokun, A., & Olusola, A. A. (2017). Effect of self-monitoring of blood glucose on glycaemic outcome among type 2 diabetic patients. South African Family Practice, 59(6), 208–213. http://dx.doi.org/10.1080/20786190.2017.1340250
Somm, E., Schwitzgebel, V. M., Vauthay, D. M., Camm, E. J., Chen, C. Y., Giacobino, J. P., Sizonenko, S. V., Aubert, M. L., & Hüppi, P. S. (2008). Prenatal nicotine exposure alters early pancreatic islet and adipose tissue development with consequences on the control of body weight and glucose metabolism later in life. Endocrinology, 149(12), 6289–6299. https://doi.org/10.1210/en.2008-0361
Soulimane, S., Simon, D., Herman, W. H., Lange, C., Lee, C. M., Colagiuri, S., Shaw, J. E., Zimmet, P. Z., Magliano, D., Ferreira, S. R., Dong, Y., Zhang, L., Jorgensen, T., Tuomilehto, J., Mohan, V., Christensen, D. L., Kaduka, L., Dekker, J. M., Nijpels, G., Stehouwer, C. D., … DESIR Study Group (2014). HbA1c, fasting and 2 h plasma glucose in current, ex- and never-smokers: a meta-analysis. Diabetologia, 57(1), 30–39. https://doi.org/10.1007/s00125-013-3058-y
Soumerai, S. B., Mah, C., Zhang, F., Adams, A., Barton, M., Fajtova, V., & Ross-Degnan, D. (2004). Effects of health maintenance organization coverage of self-monitoring devices on diabetes self-care and glycemic control. Archives of internal medicine, 164(6), 645–652. https://doi.org/10.1001/archinte.164.6.645
Spector, T. D., & Blake, D. R. (1988). Effect of cigarette smoking on Langerhans' cells. Lancet (London, England), 2(8618), 1028. https://doi.org/10.1016/s0140-6736(88)90794-5
Spijkerman, A. M., van der A, D. L., Nilsson, P. M., Ardanaz, E., Gavrila, D., Agudo, A., Arriola, L., Balkau, B., Beulens, J. W., Boeing, H., de Lauzon-Guillain, B., Fagherazzi, G., Feskens, E. J., Franks, P. W., Grioni, S., Huerta, J. M., Kaaks, R., Key, T. J., Overvad, K., … Wareham, N. J. (2014). Smoking and long-term risk of type 2 diabetes: the EPIC-InterAct study in European populations. Diabetes care, 37(12), 3164–3171. https://doi.org/10.2337/dc14-1020
Stark Casagrande, S., Fradkin, J. E., Saydah, S. H., Rust, K. F., & Cowie, C. C. (2013). The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010. Diabetes care, 36(8), 2271–2279. https://doi.org/10.2337/dc12-2258
Stratton, I. M., Adler, A. I., Neil, H. A., Matthews, D. R., Manley, S. E., Cull, C. A., Hadden, D., Turner, R. C., & Holman, R. R. (2000). Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ (Clinical research ed.), 321(7258), 405–412. https://doi.org/10.1136/bmj.321.7258.405
Subramanian, S., & Chait, A. (2012). Hypertriglyceridemia secondary to obesity and diabetes. Biochimica et biophysica acta, 1821(5), 819–825. https://doi.org/10.1016/j.bbalip.2011.10.003
Sugden, M., & Holness, M. (2011). Pathophysiology of diabetic dyslipidemia: implications for atherogenesis and treatment. Clinical Lipidology, 6(4), 401–411. https://doi.org/10.2217/clp.11.32
Svensson, E., Baggesen, L. M., Thomsen, R. W., Lyngaa, T., Pedersen, L., Nørrelund, H., Buhl, E. S., Haase, C. L., & Johnsen, S. P. (2016). Patient-level predictors of achieving early glycaemic control in Type 2 diabetes mellitus: a population-based study. Diabetic medicine : a journal of the British Diabetic Association, 33(11), 1516–1523. https://doi.org/10.1111/dme.13184
Talamini, G., Bassi, C., Falconi, M., Sartori, N., Salvia, R., Rigo, L., Castagnini, A., Di Francesco, V., Frulloni, L., Bovo, P., Vaona, B., Angelini, G., Vantini, I., Cavallini, G., & Pederzoli, P. (1999). Alcohol and smoking as risk factors in chronic pancreatitis and pancreatic cancer. Digestive diseases and sciences, 44(7), 1303–1311. https://doi.org/10.1023/a:1026670911955
Targher, G., Alberiche, M., Zenere, M. B., Bonadonna, R. C., Muggeo, M., & Bonora, E. (1997). Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus. The Journal of clinical endocrinology and metabolism, 82(11), 3619–3624. https://doi.org/10.1210/jcem.82.11.4351
Thomas, D., & Elliott, E. J. (2009). Low glycaemic index, or low glycaemic load, diets for diabetes mellitus. The Cochrane database of systematic reviews, 2009(1), CD006296. https://doi.org/10.1002/14651858.CD006296.pub2
Thomas, G. A., Rhodes, J., & Ingram, J. R. (2005). Mechanisms of disease: nicotine--a review of its actions in the context of gastrointestinal disease. Nature clinical practice. Gastroenterology & hepatology, 2(11), 536–544. https://doi.org/10.1038/ncpgasthep0316
Tomah, S., Mahmoud, N., Mottalib, A., Pober, D. M., Tasabehji, M. W., Ashrafzadeh, S., & Hamdy, O. (2019). Frequency of self-monitoring of blood glucose in relation to weight loss and A1C during intensive multidisciplinary weight management in patients with type 2 diabetes and obesity. BMJ open diabetes research & care, 7(1), e000659. https://doi.org/10.1136/bmjdrc-2019-000659
Tominaga, Y., Aomori, T., Hayakawa, T., Morisky, D. E., Takahashi, K., & Mochizuki, M. (2018). Relationship between medication adherence and glycemic control in Japanese patients with type 2 diabetes. Die Pharmazie, 73(10), 609–612. https://doi.org/10.1691/ph.2018.8587
Travier, N., Agudo, A., May, A. M., Gonzalez, C., Luan, J., Wareham, N. J., Bueno-de-Mesquita, H. B., van den Berg, S. W., Slimani, N., Rinaldi, S., Clavel-Chapelon, F., Boutron-Ruault, M. C., Palli, D., Sieri, S., Mattiello, A., Tumino, R., Vineis, P., Norat, T., Romaguera, D., Rodriguez, L., … Peeters, P. H. (2012). Longitudinal changes in weight in relation to smoking cessation in participants of the EPIC-PANACEA study. Preventive medicine, 54(3-4), 183–192. https://doi.org/10.1016/j.ypmed.2011.09.003
Tsujimoto, A., Tanino, S., & Kurogochi, Y. (1965). Effect of nicotine on serum potassium and blood glucose. Japanese journal of pharmacology, 15(4), 415–422. https://doi.org/10.1254/jjp.15.415
Tweed, J. O., Hsia, S. H., Lutfy, K., & Friedman, T. C. (2012). The endocrine effects of nicotine and cigarette smoke. Trends in endocrinology and metabolism: TEM, 23(7), 334–342. https://doi.org/10.1016/j.tem.2012.03.006
U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group. (1995). Diabetes, 44(11), 1249–1258.
U.S. National Center for Chronic Disease Prevention and Health Promotion Office on Smoking and Health. (2014). The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Centers for Disease Control and Prevention (US). Available at : https://www.ncbi.nlm.nih.gov/books/NBK179276/
Umpierre, D., Ribeiro, P. A., Kramer, C. K., Leitão, C. B., Zucatti, A. T., Azevedo, M. J., Gross, J. L., Ribeiro, J. P., & Schaan, B. D. (2011). Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis. JAMA, 305(17), 1790–1799. https://doi.org/10.1001/jama.2011.576
Umpierre, D., Ribeiro, P. A., Schaan, B. D., & Ribeiro, J. P. (2013). Volume of supervised exercise training impacts glycaemic control in patients with type 2 diabetes: a systematic review with meta-regression analysis. Diabetologia, 56(2), 242–251. https://doi.org/10.1007/s00125-012-2774-z
van Geenen, E. J., Smits, M. M., Schreuder, T. C., van der Peet, D. L., Bloemena, E., & Mulder, C. J. (2011). Smoking is related to pancreatic fibrosis in humans. The American journal of gastroenterology, 106(6), 1161–1167. https://doi.org/10.1038/ajg.2011.43
Varanka-Ruuska, T., Rautio, N., Lehtiniemi, H., Miettunen, J., Keinänen-Kiukaanniemi, S., Sebert, S., & Ala-Mursula, L. (2018). The association of unemployment with glucose metabolism: a systematic review and meta-analysis. International journal of public health, 63(4), 435–446. https://doi.org/10.1007/s00038-017-1040-z
Virdi, N., Daskiran, M., Nigam, S., Kozma, C., & Raja, P. (2012). The association of self-monitoring of blood glucose use with medication adherence and glycemic control in patients with type 2 diabetes initiating non-insulin treatment. Diabetes technology & therapeutics, 14(9), 790–798. https://doi.org/10.1089/dia.2012.0047
Walraven, I., Mast, M. R., Hoekstra, T., Jansen, A. P., van der Heijden, A. A., Rauh, S. P., Rutters, F., van 't Riet, E., Elders, P. J., Moll, A. C., Polak, B. C., Dekker, J. M., & Nijpels, G. (2015). Distinct HbA1c trajectories in a type 2 diabetes cohort. Acta diabetologica, 52(2), 267–275. https://doi.org/10.1007/s00592-014-0633-8
Wang, S., Ji, X., Zhang, Z., & Xue, F. (2020). Relationship between Lipid Profiles and Glycemic Control Among Patients with Type 2 Diabetes in Qingdao, China. International journal of environmental research and public health, 17(15), 5317. https://doi.org/10.3390/ijerph17155317
Wascher T. C. (1997). Endothelial transport processes and tissue metabolism: evidence for microvascular endothelial dysfunction in insulin-resistant diseases?. European journal of clinical investigation, 27(10), 831–835. https://doi.org/10.1046/j.1365-2362.1997.1930745.x
Welschen, L. M., Bloemendal, E., Nijpels, G., Dekker, J. M., Heine, R. J., Stalman, W. A., & Bouter, L. M. (2005). Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes care, 28(6), 1510–1517. https://doi.org/10.2337/diacare.28.6.1510
Wheeler, M. L., Dunbar, S. A., Jaacks, L. M., Karmally, W., Mayer-Davis, E. J., Wylie-Rosett, J., & Yancy, W. S., Jr (2012). Macronutrients, food groups, and eating patterns in the management of diabetes: a systematic review of the literature, 2010. Diabetes care, 35(2), 434–445. https://doi.org/10.2337/dc11-2216
White, M. G., Shaw, J. A., & Taylor, R. (2016). Type 2 Diabetes: The Pathologic Basis of Reversible β-Cell Dysfunction. Diabetes care, 39(11), 2080–2088. https://doi.org/10.2337/dc16-0619
Wilkins, J. N., Carlson, H. E., Van Vunakis, H., Hill, M. A., Gritz, E., & Jarvik, M. E. (1982). Nicotine from cigarette smoking increases circulating levels of cortisol, growth hormone, and prolactin in male chronic smokers. Psychopharmacology, 78(4), 305–308. https://doi.org/10.1007/BF00433730
Will, J. C., Galuska, D. A., Ford, E. S., Mokdad, A., & Calle, E. E. (2001). Cigarette smoking and diabetes mellitus: evidence of a positive association from a large prospective cohort study. International journal of epidemiology, 30(3), 540–546. https://doi.org/10.1093/ije/30.3.540
Willi, C., Bodenmann, P., Ghali, W. A., Faris, P. D., & Cornuz, J. (2007). Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA, 298(22), 2654–2664. https://doi.org/10.1001/jama.298.22.2654
Wittel, U. A., Pandey, K. K., Andrianifahanana, M., Johansson, S. L., Cullen, D. M., Akhter, M. P., Brand, R. E., Prokopczyk, B., & Batra, S. K. (2006). Chronic pancreatic inflammation induced by environmental tobacco smoke inhalation in rats. The American journal of gastroenterology, 101(1), 148–159. https://doi.org/10.1111/j.1572-0241.2006.00405.x
Woerle, H. J., Neumann, C., Zschau, S., Tenner, S., Irsigler, A., Schirra, J., Gerich, J. E., & Göke, B. (2007). Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes Importance of postprandial glycemia to achieve target HbA1c levels. Diabetes research and clinical practice, 77(2), 280–285. https://doi.org/10.1016/j.diabres.2006.11.011
World Health Organization, Regional Office for the Western Pacific (WPRO), International Association for the Study of Obesity, International Obesity Task Force. (2000). The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia Pty Ltd.
World Health Organization. (2018). 2018 Global progress report on implementation of the WHO framework convention on tobacco control. Available at http://www.who.int/tobacco/mpower/2009/en/index.html (accessed on October 20, 2020).
Wu, Y., Song, P., Zhang, W., Liu, J., Dai, X., Liu, Z., Lu, Q., Ouyang, C., Xie, Z., Zhao, Z., Zhuo, X., Viollet, B., Foretz, M., Wu, J., Yuan, Z., & Zou, M. H. (2015). Activation of AMPKα2 in adipocytes is essential for nicotine-induced insulin resistance in vivo. Nature medicine, 21(4), 373–382. https://doi.org/10.1038/nm.3826
Wysham, C., & Shubrook, J. (2020). Beta-cell failure in type 2 diabetes: mechanisms, markers, and clinical implications. Postgraduate medicine, 132(8), 676–686. https://doi.org/10.1080/00325481.2020.1771047
Xiao, X., Cui, X., Zhang, J., Han, Z., Xiao, Y., Chen, N., Li, B., Cheng, M., Gao, H., & Tang, K. (2016). Effects of sitagliptin as initial therapy in newly diagnosed elderly type 2 diabetics: A randomized controlled study. Experimental and therapeutic medicine, 12(5), 3002–3008. https://doi.org/10.3892/etm.2016.3729
Xie, X. T., Liu, Q., Wu, J., & Wakui, M. (2009). Impact of cigarette smoking in type 2 diabetes development. Acta pharmacologica Sinica, 30(6), 784–787. https://doi.org/10.1038/aps.2009.49
Xu, Y., Tan, D., & Lee, J. Y. (2019). Evaluating the impact of self-monitoring of blood glucose frequencies on glucose control in patients with type 2 diabetes who do not use insulin: A systematic review and meta-analysis. International journal of clinical practice, 73(7), e13357. https://doi.org/10.1111/ijcp.13357
Yabe, D., Seino, Y., Fukushima, M., & Seino, S. (2015). β cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East Asians. Current diabetes reports, 15(6), 602. https://doi.org/10.1007/s11892-015-0602-9
Yildiz D. (2004). Nicotine, its metabolism and an overview of its biological effects. Toxicon : official journal of the International Society on Toxinology, 43(6), 619–632. https://doi.org/10.1016/j.toxicon.2004.01.017
Yin, J., Yeung, R., Luk, A., Tutino, G., Zhang, Y., Kong, A., Chung, H., Wong, R., Ozaki, R., Ma, R., Tsang, C. C., Tong, P., So, W., & Chan, J. (2016). Gender, diabetes education, and psychosocial factors are associated with persistent poor glycemic control in patients with type 2 diabetes in the Joint Asia Diabetes Evaluation (JADE) program. Journal of diabetes, 8(1), 109–119. https://doi.org/10.1111/1753-0407.12262
Yoshikawa, H., Hellström-Lindahl, E., & Grill, V. (2005). Evidence for functional nicotinic receptors on pancreatic beta cells. Metabolism: clinical and experimental, 54(2), 247–254. https://doi.org/10.1016/j.metabol.2004.08.020
Young, L. A., Buse, J. B., Weaver, M. A., Vu, M. B., Mitchell, C. M., Blakeney, T., Grimm, K., Rees, J., Niblock, F., Donahue, K. E., & Monitor Trial Group (2017). Glucose Self-monitoring in Non-Insulin-Treated Patients With Type 2 Diabetes in Primary Care Settings: A Randomized Trial. JAMA internal medicine, 177(7), 920–929. https://doi.org/10.1001/jamainternmed.2017.1233
Yuan, S., & Larsson, S. C. (2019). A causal relationship between cigarette smoking and type 2 diabetes mellitus: A Mendelian randomization study. Scientific reports, 9(1), 19342. https://doi.org/10.1038/s41598-019-56014-9
Yun, J. E., Kimm, H., Choi, Y. J., Jee, S. H., & Huh, K. B. (2012). Smoking is associated with abdominal obesity, not overall obesity, in men with type 2 diabetes. Journal of preventive medicine and public health = Yebang Uihakhoe chi, 45(5), 316–322. https://doi.org/10.3961/jpmph.2012.45.5.316
Zeiher, A. M., Schächinger, V., & Minners, J. (1995). Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation, 92(5), 1094–1100. https://doi.org/10.1161/01.cir.92.5.1094
Zhang, L., Curhan, G. C., Hu, F. B., Rimm, E. B., & Forman, J. P. (2011). Association between passive and active smoking and incident type 2 diabetes in women. Diabetes care, 34(4), 892–897. https://doi.org/10.2337/dc10-2087
Zheng, Y., Ley, S. H., & Hu, F. B. (2018). Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nature reviews. Endocrinology, 14(2), 88–98. https://doi.org/10.1038/nrendo.2017.151
Zhu, H. T., Yu, M., Hu, H., He, Q. F., Pan, J., & Hu, R. Y. (2019). Factors associated with glycemic control in community-dwelling elderly individuals with type 2 diabetes mellitus in Zhejiang, China: a cross-sectional study. BMC endocrine disorders, 19(1), 57. https://doi.org/10.1186/s12902-019-0384-1
Zhu, H., Zhu, Y., & Leung, S. W. (2016). Is self-monitoring of blood glucose effective in improving glycaemic control in type 2 diabetes without insulin treatment: a meta-analysis of randomised controlled trials. BMJ open, 6(9), e010524. https://doi.org/10.1136/bmjopen-2015-010524
Zoli, M., & Picciotto, M. R. (2012). Nicotinic regulation of energy homeostasis. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 14(11), 1270–1290. https://doi.org/10.1093/ntr/nts159
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top